Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > TYRA-300 for Sale > dabogratinib Tyra 300-2800223-30-5
dabogratinib Tyra 300-2800223-30-5 buy - large image1
dabogratinib Tyra 300-2800223-30-5 buy - image1

dabogratinib Tyra 300-2800223-30-5

253 Inquiries

Unit Price: Get Latest Price
CAS No.:

2800223-30-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

china

Packaging:

1g

Price valid (until):

2026-08-12

Company Type:
Trader
Location:
United States
Payment Terms:
TT against copy of documents,100% TT in advance
Qualification:
Main Products:

peptides

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Pls input...

    Items Specifications
    TYRA-300 is an investigational, once-daily oral medication designed to selectively inhibit FGFR3 (Fibroblast Growth Factor Receptor 3) while sparing other FGFR types.




    ECHEMI Editorial Reference
    Dabogratinib(TYRA-300) , a 3-pyridylindazole analog, is a reversible and selective inhibitor of FGFR3 with an IC50 of 11 nM in Ba/F3 cells. It also exhibit potent activity in human bladder cancer cell lines harboring FGFR3 activating fusions or mutations.

    Basic Info
    Product Name:

    TYRA-300

    Other Name:

    TYRA-300;2,6-Diazaspiro[3.3]heptane, 2-[5-[5-[(1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]-2-pyridinyl]-6-(methylsulfonyl)-;(R)-5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(6-(6-(methylsulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-3-yl)-1H-indazole;TYRA-300(Dabogratinib);Tyra-300 99% Shaanxi Dideu Medichem

    CAS No.:

    2800223-30-5

    Molecular Formula:

    C25H24Cl2N6O3S

    InChIKeys:

    JOAFWIHZEBKYQK-OAHLLOKOSA-N

    Molecular Weight:

    559.47

    EC Number:

    610-261-8

    Characteristics
    Density:

    1.58±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

    Boiling Point:

    791.2±70.0 °C(predicted)

    PKA:

    11.87±0.40(predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides

    Location:

    126 AUTUMN ROAD ,LAKEWOOD NEW JERSEY

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2023

    Company Certificates
    • 38 ASHFORD ROAD LLCcertifacate for peptieds certifacate for peptieds
  • Inquiry History
    253 Inquiries
    Country Product Purchase Quantity Date Posted
    United Kingdom

    TYRA-300

    50 G Oct 29, 2026
    Germany

    Tyra-300

    5 G Oct 28, 2026
    United States

    Dabogratinib

    1 G Oct 28, 2026
    United States

    TYRA-300 Dabogratinib

    1 G Oct 27, 2026
    United States

    tyra-300

    1 G Oct 27, 2026
    United States

    tesa,reta,ghkcu,bac water

    50 MT Oct 26, 2026
    China

    TYRA-300

    1 G Oct 26, 2026
    United States

    dabogratinib (tyra-300)

    1 G Oct 25, 2026
    United States

    Dabogratinib

    5 G Oct 24, 2026
    United States

    Dabogratinib

    1 G Oct 24, 2026
    Netherlands

    Tyra-300/dabogratinib

    1 G Oct 23, 2026
    Canada

    Tyra300

    6 G Oct 23, 2026
    Portugal

    TYRA 300

    100 G Oct 22, 2026
    United Kingdom

    Tyra300

    2 G Oct 21, 2026
    United States

    Tyra-300

    1 MT Oct 20, 2026
    South Africa

    Tyra 300

    19 G Oct 20, 2026
    Jordan

    tyra-300

    1 G Oct 19, 2026
    Germany

    TYRA-300

    5 MG Oct 19, 2026
    United States

    Tyra-300

    1 G Oct 18, 2026
    United Kingdom

    Tyra 300

    1 G Oct 17, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.